X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (297) 297
male (226) 226
middle aged (164) 164
aged (149) 149
index medicus (139) 139
urology (130) 130
female (127) 127
oncology (109) 109
adult (104) 104
urology & nephrology (95) 95
prostate cancer (88) 88
cancer (70) 70
aged, 80 and over (56) 56
risk factors (54) 54
polymorphism, genetic (45) 45
genotype (44) 44
prognosis (44) 44
kidney transplantation (43) 43
prostatic neoplasms - pathology (41) 41
transplantation (41) 41
care and treatment (39) 39
prostatic neoplasms - genetics (39) 39
surgery (39) 39
metastasis (38) 38
bladder cancer (34) 34
chemotherapy (34) 34
genetic aspects (34) 34
retrospective studies (34) 34
tacrolimus (34) 34
analysis (33) 33
expression (33) 33
japan (33) 33
survival (33) 33
research (32) 32
urinary bladder neoplasms - genetics (32) 32
kidneys (31) 31
neoplasm staging (31) 31
polymorphism (31) 31
treatment outcome (31) 31
animals (30) 30
carcinoma (30) 30
medical colleges (30) 30
tumors (30) 30
health aspects (29) 29
genetic predisposition to disease (26) 26
alleles (25) 25
disease progression (24) 24
pharmacology & pharmacy (24) 24
prostatic neoplasms - surgery (24) 24
risk (24) 24
urinary bladder neoplasms - pathology (24) 24
area under curve (23) 23
prostatectomy (23) 23
renal transplantation (23) 23
carcinoma, transitional cell - genetics (22) 22
case-control studies (22) 22
renal cell carcinoma (22) 22
laparoscopy (21) 21
mice (21) 21
prostate-specific antigen - blood (21) 21
gene (20) 20
immunosuppressive agents - pharmacokinetics (20) 20
medicine & public health (20) 20
radical prostatectomy (20) 20
kidney neoplasms - pathology (19) 19
men (19) 19
pharmacokinetics (19) 19
polymerase chain reaction (19) 19
polymorphism, single nucleotide (19) 19
mutation (18) 18
antineoplastic combined chemotherapy protocols - therapeutic use (17) 17
diagnosis (17) 17
genetic polymorphisms (17) 17
kidney neoplasms - genetics (17) 17
oncology, experimental (17) 17
patient outcomes (17) 17
time factors (17) 17
cell line, tumor (16) 16
cyclosporine (16) 16
nephrectomy - methods (16) 16
prostatic neoplasms - blood (16) 16
survival analysis (16) 16
young adult (16) 16
breast-cancer (15) 15
immunohistochemistry (15) 15
tacrolimus - pharmacokinetics (15) 15
urinary bladder neoplasms - surgery (15) 15
article (14) 14
biomarkers, tumor - blood (14) 14
cells (14) 14
disease-free survival (14) 14
docetaxel (14) 14
genetics (14) 14
genetics & heredity (14) 14
immunosuppressive agents - administration & dosage (14) 14
medical research (14) 14
mycophenolic acid (14) 14
pathology (14) 14
patients (14) 14
studies (14) 14
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Drug Delivery System, ISSN 0913-5006, 12/2014, Volume 29, Issue 4, pp. 271 - 271
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2008, Volume 14, Issue 23, pp. 7956 - 7962
Journal Article
The Journal of Urology, ISSN 0022-5347, 04/2018, Volume 199, Issue 4, pp. e371 - e371
Journal Article
Nihon rinsho. Japanese journal of clinical medicine, ISSN 0047-1852, 01/2016, Volume 74, Issue 1, pp. 40 - 44
Journal Article
Japanese Journal of Clinical Urology, ISSN 0385-2393, 11/2012, Volume 66, Issue 12, pp. 931 - 940
Journal Article
Journal Article
International Journal of Urology, ISSN 0919-8172, 03/2018, Volume 25, Issue 3, pp. 263 - 268
Objectives To evaluate the current status of urological laparoendoscopic single‐site and reduced port surgery in Japan. Methods Of the 152 institutions to... 
laparoendoscopic single‐site surgery | Japan | reduced port surgery | urology | laparoendoscopic single-site surgery | METAANALYSIS | INITIAL-EXPERIENCE | CONVENTIONAL LAPAROSCOPIC NEPHRECTOMY | UROLOGY & NEPHROLOGY | MULTIINSTITUTIONAL ANALYSIS | COMPLICATIONS | ADRENALECTOMY | Surveys | Surgery | Adrenalectomy | Laparoscopy | Nephrectomy
Journal Article
Future Oncology, ISSN 1479-6694, 04/2006, Volume 2, Issue 2, pp. 233 - 245
To date, most molecular epidemiological studies on gene polymorphisms in cancer have focused on the risk of development and susceptibility to cancer. However,... 
Prognosis | Androgen | Genetics | Microenvironment | Prostate cancer | Growth factor | Polymorphism | Genetic Predisposition to Disease | Prostatic Neoplasms - genetics | Humans | Male | Prostatic Neoplasms - diagnosis | Neoplasm Proteins - genetics | Polymorphism, Genetic
Journal Article
by Kote-Jarai, Zsofia and Olama, Ali Amin Al and Giles, Graham G and Severi, Gianluca and Schleutker, Johanna and Weischer, Maren and Campa, Daniele and Riboli, Elio and Key, Tim and Gronberg, Henrik and Hunter, David J and Kraft, Peter and Thun, Michael J and Ingles, Sue and Chanock, Stephen and Albanes, Demetrius and Hayes, Richard B and Neal, David E and Hamdy, Freddie C and Donovan, Jenny L and Pharoah, Paul and Schumacher, Fredrick and Henderson, Brian E and Stanford, Janet L and Ostrander, Elaine A and Sorensen, Karina Dalsgaard and Dörk, Thilo and Andriole, Gerald and Dickinson, Joanne L and Cybulski, Cezary and Lubinski, Jan and Spurdle, Amanda and Clements, Judith A and Chambers, Suzanne and Aitken, Joanne and Gardiner, R. A. Frank and Thibodeau, Stephen N and Schaid, Dan and John, Esther M and Maier, Christiane and Vogel, Walther and Cooney, Kathleen A and Park, Jong Y and Cannon-Albright, Lisa and Brenner, Hermann and Habuchi, Tomonori and Zhang, Hong-Wei and Lu, Yong-Jie and Kaneva, Radka and Muir, Ken and Benlloch, Sara and Leongamornlert, Daniel A and Saunders, Edward J and Tymrakiewicz, Malgorzata and Mahmud, Nadiya and Guy, Michelle and O'Brien, Lynne T and Wilkinson, Rosemary A and Hall, Amanda L and Sawyer, Emma J and Dadaev, Tokhir and Morrison, Jonathan and Dearnaley, David P and Horwich, Alan and Huddart, Robert A and Khoo, Vincent S and Parker, Christopher C and Van As, Nicholas and Woodhouse, Christopher J and Thompson, Alan and Christmas, Tim and Ogden, Chris and Cooper, Colin S and Lophatonanon, Aritaya and Southey, Melissa C and Hopper, John L and English, Dallas R and Wahlfors, Tiina and Tammela, Teuvo L. J and Klarskov, Peter and Nordestgaard, Børge G and Røder, M Andreas and Tybjarg-Hansen, Anne and Bojesen, Stig E and Travis, Ruth and Canzian, Federico and Kaaks, Rudolf and Wiklund, Fredrik and Aly, Markus and Lindstrom, Sara and Diver, W Ryan and Gapstur, Susan and Stern, Mariana C and Corral, Roman and Virtamo, Jarmo and Cox, Angela and Haiman, Christopher A and Le Marchand, Loic and Fitzgerald, Liesel and Kolb, Suzanne and ... and UK ProtecT Study Collaborators and Australian Prostate Canc BioResour and PRACTCTICAL Consortium and UK Genetic Prostate Canc Study Col and PRACTICAL Consortium and UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology and UK ProtecT Study Collaborators, The Australian Prostate Cancer BioResource and The PRACTICAL Consortium and The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology and The UK ProtecT Study Collaborators, The Australian Prostate Cancer BioResource
Nature Genetics, ISSN 1061-4036, 08/2011, Volume 43, Issue 8, pp. 785 - 791
Journal Article
Clinical and Experimental Nephrology, ISSN 1342-1751, 10/2017, Volume 21, Issue 5, pp. 787 - 796
We investigated the impact of the CYP3A5 genotype on the distributions of dose-adjusted trough concentrations (C 0h/D) and the incidence of rejection in... 
Rejection | Nephrology | Medicine & Public Health | Tacrolimus | Formulation | Renal transplantation | CYP3A5 genotype | Dose-adjusted trough concentration | Urology | POPULATION | DETERMINANTS | TWICE-DAILY TACROLIMUS | INTRAPATIENT VARIABILITY | PHARMACODYNAMICS | PHARMACOKINETICS | KIDNEY-TRANSPLANTATION | UROLOGY & NEPHROLOGY | ABCB1 POLYMORPHISMS | PHARMACOGENETICS | SINGLE NUCLEOTIDE POLYMORPHISMS | Japan - epidemiology | Multivariate Analysis | Calcineurin Inhibitors - pharmacokinetics | Humans | Immunosuppressive Agents - pharmacokinetics | Asian Continental Ancestry Group - genetics | Incidence | Calcineurin Inhibitors - blood | Drug Dosage Calculations | Immunosuppressive Agents - blood | Cytochrome P-450 CYP3A - genetics | Drug Compounding | Pharmacogenomic Variants | Odds Ratio | Immunosuppressive Agents - administration & dosage | Tacrolimus - administration & dosage | Pharmacogenetics | Calcineurin Inhibitors - administration & dosage | Graft Rejection - prevention & control | Risk Factors | Genotype | Logistic Models | Treatment Outcome | Tacrolimus - pharmacokinetics | Chi-Square Distribution | Tacrolimus - adverse effects | Calcineurin Inhibitors - adverse effects | Cytochrome P-450 CYP3A - metabolism | Graft Rejection - ethnology | Immunosuppressive Agents - adverse effects | Graft Rejection - immunology | Drug Monitoring | Graft Rejection - genetics | Graft Survival - drug effects | Kidney Transplantation - adverse effects | Kidneys | Analysis | Organ transplant recipients | Genetic aspects | Transplantation | Kidney diseases | Transplants & implants | Alleles | Health risk assessment | Gene polymorphism | Graft rejection | Kidney transplantation
Journal Article
Journal Article
SCIENTIFIC REPORTS, ISSN 2045-2322, 09/2019, Volume 9, Issue 1, pp. 1 - 8
Phosphoinositides (PIPs) participate in many cellular processes, including cancer progression; however, the metabolic features of PIPs associated with prostate... 
SUPPRESSOR | INPP4B | INHIBITION | DE-NOVO LIPOGENESIS | MULTIDISCIPLINARY SCIENCES | CELL-PROLIFERATION | ACID SYNTHASE | DECREASED EXPRESSION | Phosphoinositides | Phosphatidylinositol 3,4,5-triphosphate | Hyperplasia | Cell lines | Mass spectroscopy | Tumor cell lines | Phosphatidylinositol 4,5-diphosphate | Prostate cancer | PTEN protein | Phosphatidylinositol phosphates
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.